Skip to main content
Clinical Trials/NCT06167356
NCT06167356
Recruiting
N/A

Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).

IRCCS San Raffaele1 site in 1 country20,000 target enrollmentNovember 27, 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Non Muscle Invasive Bladder Cancer
Sponsor
IRCCS San Raffaele
Enrollment
20000
Locations
1
Primary Endpoint
improve the patient's scientific knowledge and develop new procedures for the diagnosis and treatment of the patient
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.

Detailed Description

Each patient will be followed for approximately 10 years starting from the date of surgery. The patient may be contacted for yearly follow-up through one of the preferred methods indicated (phone call, email or home address) which will be carried out by the staff of the Urology Department. The data for each patient will then be transferred to the database itself. The data collected will be handled follwing the most strict GCPs and privacy norms. The data entered will concern: * period before hospitalization (symptoms, clinical data) and completion of a pre-surgery questionnaire * hospitalization period with all its related data * questionnaires relating to quality of life which will be administered to the patient once a year according to the preferred method expressed by the patient in the informed consent.

Registry
clinicaltrials.gov
Start Date
November 27, 2013
End Date
November 27, 2063
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Francesco Montorsi

Professor

IRCCS San Raffaele

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Patients with non-muscle invasive bladder cancer
  • Indication to cancer removal through endoscopic resection surgery
  • Ability to read and sign the informed consent

Exclusion Criteria

  • Age \<18 years
  • Inability to read and sign the informed consent

Outcomes

Primary Outcomes

improve the patient's scientific knowledge and develop new procedures for the diagnosis and treatment of the patient

Time Frame: 1 Annual follow-up from the date of surgery untile the date in which patient decides to stop providing follow-up responses or until the date of death from any cause.

Through the collection of a detailed clinical history of the patient in which themselves report symptoms, diagnosis and previous urological and non-urological treatments and also through the medical record.

obtain health benefit for the patients themselves and for future patients suffering from bladder cancer

Time Frame: 1 Annual follow-up from the date of surgery until the date in which patient decides to stop providing follow-up responses or until the date of death from any cause.

All patients, before underwent endoscopic resection surgery, receive a diary in which we ask a detailed clinical history of the patient with their symptoms, diagnosis and previous urological e non urological treatments performed before the operation. A detailed intraoperative, postoperative and follow-up clinical history

Study Sites (1)

Loading locations...

Similar Trials

Terminated
N/A
The Chimerix CMX001 RegistryOutcomesSurvival Rates
NCT02167685Chimerix550
Recruiting
N/A
Data Collection of Patients Admitted to the Stroke UnitStrokeStroke, AcuteStroke, IschemicStroke HemorrhagicStroke Sequelae
NCT04956185University Hospital, Ghent5,000
Completed
N/A
Epidemiological study for constructing database of intestinal immunity and flora for healthy Japanese population contributing to new prevention methods establishment of lifestyle-related diseases and allergic diseaselifestyle-related diseases and allergic disease
JPRN-UMIN000023270Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition1,200
Recruiting
N/A
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerCancer RiskCancer Predisposition SyndromeHereditary Cancer PredictionChildhood Cancer SurvivorsAdult Cancer SurvivorsIARC CarcinogensSmoking HistoryLung CancerDuctal/Lobular CarcinomaBarrett EsophagusPancreatic Precursor LesionsColonic Dysplasia/AdenomataNon-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisCirrhosisHigh Grade Prostatic Epithelial NeoplasiaHigh-grade Bladder Urothelial Dysplasia/Carcinoma in SituAdenomatous HyperplasiaHigh-risk Oral Precancerous DiseasesMelanocytic Lesion, AdultHematologic MalignancyLung; NodeSerous Tubal Intraepithelial CarcinomaEndometrial Intraepithelial NeoplasiaCervical and Endocervical Carcinoma in SituVulvar Intraepithelial NeoplasiaNephrogenic RestsBenign Bone Lesions With Risk of Malignant DegenerationGiant Cell TumorOsteochondromaSpitz Nevus
NCT05463796Dana-Farber Cancer Institute5,000
Completed
N/A
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque PsoriasisModerate to Severe Plaque Psoriasis
NCT01555606Janssen Biotech, Inc.108